Search
 
 

Complete Chromosome Analysis for IVF Patients

Park Avenue Fertility is pleased to announce 24
Chromosome Embryo Screening by Array
Comparative Genome Hybridization (aCGH)!

Chromosomal abnormalities are major causes for low pregnancy rates and high miscarriage rates among patients undergoing IVF. Preimplantation genetic diagnosis (PGD) is a technology that seeks to provide a means of identifying potentially viable euploid (chromosomally normal) embryos for transfer.

Historically, PGD has involved analysis of a single cell followed by fluorescence in situ hybridization (FISH) using probes for a limited number of chromosomes (5-12 chromosomes). FISH, which screens for only up to half of all chromosomes, appears to have reduced diagnostic accuracy when compared to testing where all 24 chromosomes are evaluated.

Park Avenue Fertility is now offering 24 chromosome PGD by Array Comparative Genome Hybridization (aCGH) which examines all 24 chromosomes from the biopsied cells. The aCGH technique can also be used not only to test for chromosomal aneuploidy (the number of copies of each chromosome) but can also identify other chromosomal issues, including translocations and inversions.

We are excited to offer this new cutting-edge technology at Park Avenue Fertility. If you have any questions about IVF, PGD, and aCGH, please contact Park Avenue Fertility so we can better help you.